Author:
Walenga Jeanine M.,Prechel M. Margaret
Publisher
Springer International Publishing
Reference54 articles.
1. Hoh BL, Aghi M, Pryor JC, Ogilvy CS. Heparin-induced thrombocytopenia type II in subarachnoid hemorrhage patients: incidence and complications. Neurosurgery. 2005;57(2):243–8.
2. LaMonte MP, Brown PM, Hursting MJ. Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy. Crit Care Med. 2004;32(4):976–80.
3. Pohl C, Harbrecht U, Greinacher A, et al. Neurologic complications in immune-mediated heparin-induced thrombocytopenia. Neurology. 2000;54:1240–5.
4. Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost. 1994;71:247–51.
5. Rauova L, Poncz M, McKenzie SE, et al. Ultralarge complexes of heparin and PF4 are central to the pathogenesis of heparin-induced thrombocytopenia. Blood. 2005;105:131–8.